Ready to play
Ready to play
A study published in the BMJ journal revealed that obesity treatment medications from the "GLP-1" class, such as "Tirzepatide" and "Semaglutide," are among the most effective treatments for weight loss, with losses reaching up to 15% of body weight. However, increasing their effectiveness is associated with higher rates of side effects, particularly gastrointestinal disturbances like nausea and vomiting. There is not yet sufficient evidence of a comprehensive improvement in patients' quality of life. The use of these drugs carries risks, and further studies are needed to understand their long-term effects.
Notice: This Is an AI-Generated Summary
Comments (0)